Shiv Bachan Singh

Shiv Bachan Singh

Active Director Director DIN 05114450
DIN 05114450 First appointment Dec 2011 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2011
Shareholding value •••• Premium profile

About Shiv Bachan Singh

Data last updated:

Shiv Bachan Singh is a Director at Nix Pharma Private Limited (since 2011). The company operates in Trading. Nix Pharma Private Limited reported revenue of ₹3.4 Lakh (FY 2017).

DIN 05114450
Primary Designation Director
Industry Trading
First Appointment 30 Dec 2011
Oldest Company Age 14 yrs
Largest company Nix Pharma Private Limited · ₹3.4 Lakh (FY 2017)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nix Pharma Private Limited U33111UP2011PTC048154
Director30 Dec 20112011₹3.4 Lakh (FY 2017)Active

Board colleagues of Shiv Bachan Singh

Directorship timeline

Open interactive timeline →
Nix Pharma Private Limited
Premium access

Shareholding and investment profile for Shiv Bachan Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shiv Bachan Singh

Shiv Bachan Singh currently holds 1 directorship: Nix Pharma Private Limited (Director, since 30 Dec 2011, revenue ₹3.4 Lakh (FY 2017)).

Shiv Bachan Singh was first appointed on 30 Dec 2011 as Director at Nix Pharma Private Limited.

The current boards of Shiv Bachan Singh's companies include Ravi Prakash Srivastava (Nix Pharma Private Limited), Surya Prakash (Nix Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available